Human Th17 cells lack HIV-inhibitory RNases and are highly permissive to productive HIV infection

Journal of Virology

Volumn 90, Issue 17, 2016, Pages 7833-7847

  Christensen Quick, Aaron ^a   Lafferty, Mark ^a   Sun, Lingling ^a   Marchionni, Luigi ^b   DeVico, Anthony ^a   Garzino Demo, Alfredo ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; RIBONUCLEASE; RIBONUCLEASE 2; RIBONUCLEASE 3; RIBONUCLEASE 6; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; PANCREATIC RIBONUCLEASE;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; VIRUS REPLICATION; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; GENE EXPRESSION PROFILING; HIV; HUMANS; RIBONUCLEASE, PANCREATIC; T-LYMPHOCYTE SUBSETS; TH17 CELLS; VIRUS REPLICATION;

EID: 84981208397     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02869-15     Document Type: Article

References (69)

1. Brenchley JM, Paiardini M, Knox KS, Asher AI, Cervasi B, Asher TE, Scheinberg P, Price DA, Hage CA, Kholi LM, Khoruts A, Frank I, Else J, Schacker T, Silvestri G, Douek DC. 2008. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112:2826-2835. http://dx.doi.org/10.1182/blood-2008-05-159301.
2. Raffatellu M, Santos RL, Verhoeven DE, George MD, Wilson RP, Winter SE, Godinez I, Sankaran S, Paixao TA, Gordon MA, Kolls JK, Dandekar S, Baumler AJ. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14:421-428. http://dx.doi.org/10.1038/nm1743.
3. Schuetz A, Deleage C, Sereti I, Rerknimitr R, Phanuphak N, Phuang-Ngern Y, Estes JD, Sandler NG, Sukhumvittaya S, Marovich M, Jongrakthaitae S, Akapirat S, Fletscher JL, Kroon E, Dewar R, Trichavaroj R, Chomchey N, Douek DC, O'Connell RJ, Ngauy V, Robb ML, Phanuphak P, Michael NL, Excler JL, Kim JH, de Souza MS, Ananworanich J, RV254/SEARCH 010 and RV304/SEARCH 013 Study Groups. 2014. Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation. PLoS Pathog 10:e1004543. http://dx.doi.org/10.1371/journal.ppat .1004543.
4. Hartigan-O'Connor DJ, Abel K, Van Rompay KK, Kanwar B, McCune JM. 2012. SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci Transl Med 4:136ra169. http://dx.doi.org/10.1126/scitranslmed.3003941.
5. Cecchinato V, Trindade CJ, Laurence A, Heraud JM, Brenchley JM, Ferrari MG, Zaffiri L, Tryniszewska E, Tsai WP, Vaccari M, Parks RW, Venzon D, Douek DC, O'Shea JJ, Franchini G. 2008. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol 1:279-288. http://dx.doi.org/10.1038/mi.2008.14.
6. + lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 5:646-657. http://dx.doi.org/10.1038/mi .2012.38.
7. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749-759. http://dx.doi.org/10.1084/jem.20040874.
8. Thea DM, Porat R, Nagimbi K, Baangi M, St Louis ME, Kaplan G, Dinarello CA, Keusch GT. 1996. Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 124:757-762. http://dx.doi.org/10.7326/0003-4819-124-8-199604150-00009.
9. Ilyin SE, Plata-Salaman CR. 1997. HIV-1 envelope glycoprotein 120 regulates brain IL-1beta system and TNF-alpha mRNAs in vivo. Brain Res Bull 44:67-73. http://dx.doi.org/10.1016/S0361-9230(97)00091-9.
10. Ketlinskii SA, Kalinina NM, Tsvetkova SN, Rakhmanova AG, Maslov VN, Khaldeeva NA. 1992. Tumor necrosis factor-alpha and interleukin-1beta in the blood plasma of patients with HIV infection. Vestn Ross Akad Med Nauk (9-10):36-41. (In Russian.)
11. Creemers PC, O'Shaughnessy M, Boyko WJ. 1986. Increased interleukin-2 receptor expression after mitogen stimulation on CD4-and CD8-positive lymphocytes and decreased interleukin-2 production in HTLVIII antibody-positive symptomatic individuals. Immunology 59:627-629.
12. Hirao LA, Grishina I, Bourry O, Hu WK, Somrit M, Sankaran-Walters S, Gaulke CA, Fenton AN, Li JA, Crawford RW, Chuang F, Tarara R, Marco ML, Baumler AJ, Cheng H, Dandekar S. 2014. Early mucosal sensing of SIV infection by Paneth cells induces IL-1beta production and initiates gut epithelial disruption. PLoS Pathog 10:e1004311. http://dx.doi .org/10.1371/journal.ppat.1004311.
13. Alfano M, Crotti A, Vicenzi E, Poli G. 2008. New players in cytokine control of HIV infection. Curr HIV/AIDS Rep 5:27-32. http://dx.doi.org /10.1007/s11904-008-0005-5.
14. Kedzierska K, Crowe SM. 2001. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 12:133-150. http://dx.doi .org/10.1177/095632020101200301.
15. Louis S, Dutertre CA, Vimeux L, Fery L, Henno L, Diocou S, Kahi S, Deveau C, Meyer L, Goujard C, Hosmalin A. 2010. IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection. J Leukoc Biol 87:645-653. http://dx.doi.org/10.1189/jlb.1009684.
16. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol 10:11-23. http://dx.doi.org/10.1038/nri2674.
17. + Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands. J Virol 87:10843-10854. http://dx.doi.org/10.1128/JVI.01838-13.
18. Hirota K, Ahlfors H, Duarte JH, Stockinger B. 2012. Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Rep 13:113-120. http://dx.doi.org/10.1038/embor.2011.248.
19. Kwon H, Thierry-Mieg D, Thierry-Mieg J, Kim HP, Oh J, Tunyaplin C, Carotta S, Donovan CE, Goldman ML, Tailor P, Ozato K, Levy DE, Nutt SL, Calame K, Leonard WJ. 2009. Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 31:941-952. http://dx.doi.org /10.1016/j.immuni.2009.10.008.
20. Kroenke MA, Eto D, Locci M, Cho M, Davidson T, Haddad EK, Crotty S. 2012. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 188:3734-3744. http://dx.doi.org/10.4049/jimmunol.1103246.
21. Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, Haddad EK, De Leval L, Graziosi C, Pantaleo G. 2013. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 210:143-156. http://dx.doi.org/10.1084/jem.20121932.
22. Xu Y, Weatherall C, Bailey M, Alcantara S, De Rose R, Estaquier J, Wilson K, Suzuki K, Corbeil J, Cooper DA, Kent SJ, Kelleher AD, Zaunders J. 2013. Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques. J Virol 87:3760-3773. http://dx.doi.org/10.1128/JVI.02497-12.
23. Boswell KL, Paris R, Boritz E, Ambrozak D, Yamamoto T, Darko S, Wloka K, Wheatley A, Narpala S, McDermott A, Roederer M, Haubrich R, Connors M, Ake J, Douek DC, Kim J, Petrovas C, Koup RA. 2014. Loss of circulating CD4 T cells with B cell helper function during chronic HIV infection. PLoS Pathog 10:e1003853. http://dx.doi.org/10.1371/journal.ppat.1003853.
24. + T cell subset coexpressing multiple markers of HIV susceptibility. J Immunol 187:6032-6042. http://dx.doi.org/10.4049/jimmunol.1101836.
25. Mayuzumi H, Inagaki-Ohara K, Uyttenhove C, Okamoto Y, Matsuzaki G. 2010. Interleukin-17A is required to suppress invasion of Salmonella enterica serovar Typhimurium to enteric mucosa. Immunology 131:377-385. http://dx.doi.org/10.1111/j.1365-2567.2010.03310.x.
26. Pallikkuth S, Micci L, Ende ZS, Iriele RI, Cervasi B, Lawson B, McGary CS, Rogers KA, Else JG, Silvestri G, Easley K, Estes JD, Villinger F, Pahwa S, Paiardini M. 2013. Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21. PLoS Pathog 9:e1003471. http://dx.doi.org/10.1371/journal.ppat.1003471.
27. El Hed A, Khaitan A, Kozhaya L, Manel N, Daskalakis D, Borkowsky W, Valentine F, Littman DR, Unutmaz D. 2010. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J Infect Dis 201:843-854. http://dx.doi.org/10.1086/651021.
28. + T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immunol 186:4618-4630. http://dx.doi.org/10.4049/jimmunol.1004151.
29. + T cells are highly permissive to HIV-1 infection. J Immunol 184:1604-1616. http://dx.doi.org/10.4049/jimmunol.0903058.
30. Dunay GA, Toth I, Eberhard JM, Degen O, Tolosa E, van Lunzen J, Hauber J, Schulze Zur Wiesch J. 2015. Parallel assessment of Th17 cell frequencies by surface marker coexpression versus ex vivo IL-17 production in HIV-1 infection. Cytometry B Clin Cytom http://dx.doi.org/10.1002/cyto.b.21352.
31. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, Oh S, Sabzghabaei N, Lavecchio EM, Punaro M, Pascual V, Banchereau J, Ueno H. 2011. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34:108-121. http://dx.doi.org/10.1016/j.immuni.2010.12.012.
32. Hirota K, Turner JE, Villa M, Duarte JH, Demengeot J, Steinmetz OM, Stockinger B. 2013. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat Immunol 14:372-379. http://dx.doi.org/10.1038/ni.2552.
33. Lu KT, Kanno Y, Cannons JL, Handon R, Bible P, Elkahloun AG, Anderson SM, Wei L, Sun H, O'Shea JJ, Schwartzberg PL. 2011. Functional and epigenetic studies reveal multistep differentiation and plasticity of in vitro-generated and in vivo-derived follicular T helper cells. Immunity 35:622-632. http://dx.doi.org/10.1016/j.immuni.2011.07.015.
34. Li H, Bar KJ, Wang S, Decker JM, Chen Y, Sun C, Salazar-Gonzalez JF, Salazar MG, Learn GH, Morgan CJ, Schumacher JE, Hraber P, Giorgi EE, Bhattacharya T, Korber BT, Perelson AS, Eron JJ, Cohen MS, Hicks CB, Haynes BF, Markowitz M, Keele BF, Hahn BH, Shaw GM. 2010. High multiplicity infection by HIV-1 in men who have sex with men. PLoS Pathog 6:e1000890. http://dx.doi.org/10.1371/journal.ppat.1000890.
35. Ray K, Mengistu M, Yu L, Lewis GK, Lakowicz JR, DeVico AL. 2014. Antigenic properties of the HIV envelope on virions in solution. J Virol 88:1795-1808. http://dx.doi.org/10.1128/JVI.03048-13.
36. McCall MN, Bolstad BM, Irizarry RA. 2010. Frozen robust multiarray analysis (fRMA). Biostatistics 11:242-253. http://dx.doi.org/10.1093/biostatistics/kxp059.
37. Leek JT, Storey JD. 2007. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3:1724-1735.
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550. http://dx.doi.org/10.1073/pnas.0506580102.
39. Kortenhorst MS, Wissing MD, Rodriguez R, Kachhap SK, Jans JJ, Van der Groep P, Verheul HM, Gupta A, Aiyetan PO, van der Wall E, Carducci MA, Van Diest PJ, Marchionni L. 2013. Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors. Epigenetics 8:907-920. http://dx.doi.org/10.4161/epi.25574.
40. Ross AE, Marchionni L, Phillips TM, Miller RM, Hurley PJ, Simons BW, Salmasi AH, Schaeffer AJ, Gearhart JP, Schaeffer EM. 2011. Molecular effects of genistein on male urethral development. J Urol 185:1894-1898. http://dx.doi.org/10.1016/j.juro.2010.12.095.
41. Ross AE, Marchionni L, Vuica-Ross M, Cheadle C, Fan J, Berman DM, Schaeffer EM. 2011. Gene expression pathways of high grade localized prostate cancer. Prostate 71:1568-1577. http://dx.doi.org/10.1002/pros .21373.
42. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and posttranscriptional mechanisms. J Exp Med 172:151-158. http://dx.doi.org/10.1084/jem.172.1.151.
43. Al-Harthi L, Roebuck KA, Kessler H, Landay A. 1997. Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor. J Infect Dis 176:1175-1179. http://dx.doi.org/10.1086/514110.
44. Alvarez Y, Tuen M, Nàdas A, Hioe CE. 2012. In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines. AIDS ResHumRetroviruses 28:823-834. http://dx .doi.org/10.1089/aid.2011.0184.
45. Rani A, Greenlaw R, Runglall M, Jurcevic S, John S. 2014. FRA2 is a STAT5 target gene regulated by IL-2 in human CD4 T cells. PLoS One 9:e90370. http://dx.doi.org/10.1371/journal.pone.0090370.
46. Foli A, Saville MW, Baseler MW, Yarchoan R. 1995. Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication. Blood 85:2114-2123.
47. Gonzalez MW, DeVico AL, Lewis GK, Spouge JL. 2015. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission. J Virol 89:3619-3629. http://dx.doi.org/10.1128/JVI.03235-14.
48. Abbas AR, Wolslegel K, Seshasayee D, Modrusan Z, Clark HF. 2009. Deconvolution of blood microarray data identifies cellular activation patterns in systemic lupus erythematosus. PLoS One 4:e6098. http://dx.doi .org/10.1371/journal.pone.0006098.
49. + T-cell subpopulations. Curr Opin HIV AIDS http://dx.doi.org/10.1097/COH.0000000000000281.
50. + cell decline in vivo. J Med Virol 45:91-98. http://dx.doi.org/10.1002/jmv.1890450117.
51. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. 2013. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498:376-379. http://dx.doi.org/10.1038/nature12274.
52. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Munoz-Arias I, Greene WC. 2014. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505:509-514. http://dx.doi.org/10.1038/nature12940.
53. Somasundaran M, Robinson HL. 1988. Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection. Science 242:1554-1557. http://dx.doi.org/10.1126/science.3201245.
54. Ryan ES, Micci L, Fromentin R, Paganini S, McGary CS, Easley K, Chomont N, Paiardini M. 2016. Loss of function of intestinal IL-17 and IL-22 producing cells contributes to inflammation and viral persistence in SIV-infected rhesus macaques. PLoS Pathog 12:e1005412. http://dx.doi .org/10.1371/journal.ppat.1005412.
55. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-2279. http://dx.doi.org/10.1084/jem .20061308.
56. Sun L, Finnegan CM, Kish-Catalone T, Blumenthal R, Garzino-Demo P, La Terra Maggiore GM, Berrone S, Kleinman C, Wu Z, Abdelwahab S, Lu W, Garzino-Demo A. 2005. Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol 79:14318-14329. http://dx.doi.org/10.1128/JVI.79.22.14318-14329.2005.
57. Sundaravaradan V, Mehta R, Harris DT, Zack JA, Ahmad N. 2010. Differential expression and interaction of host factors augment HIV-1 gene expression in neonatal mononuclear cells. Virology 400:32-43. http://dx.doi.org/10.1016/j.virol.2010.01.018.
58. Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, Chen X, Tang Q, Lv Z, Zhang L, Lu C. 2007. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol 81:2401-2417. http://dx .doi.org/10.1128/JVI.02024-06.
59. Che KF, Shankar EM, Muthu S, Zandi S, Sigvardsson M, Hinkula J, Messmer D, Larsson M. 2012. p38 mitogen-activated protein kinase/ signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells. Mol Med 18:1169-1182. http://dx.doi.org/10.2119/molmed.2012.00103.
60. Cleret-Buhot A, Zhang Y, Planas D, Goulet JP, Monteiro P, Gosselin A, Wacleche VS, Tremblay CL, Jenabian MA, Routy JP, El-Far M, Chomont N, Haddad EK, Sekaly RP, Ancuta P. 2015. Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach. Retrovirology 12:102. http://dx.doi.org/10.1186/s12977-015-0226-9.
61. Qiu Z, Dyer KD, Xie Z, Radinger M, Rosenberg HF. 2009. GATA transcription factors regulate the expression of the human eosinophilderived neurotoxin (RNase 2) gene. J Biol Chem 284:13099-13109. http://dx.doi.org/10.1074/jbc.M807307200.
62. Vahedi G, Poholek AC, Hand TW, Laurence A, Kanno Y, O'Shea JJ, Hirahara K. 2013. Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunol Rev 252:24-40. http://dx.doi .org/10.1111/imr.12037.
63. Rugeles MT, Trubey CM, Bedoya VI, Pinto LA, Oppenheim JJ, Rybak SM, Shearer GM. 2003. Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition. AIDS 17:481-486. http://dx.doi.org/10.1097/00002030-200303070-00002.
64. Cocchi F, DeVico AL, Lu W, Popovic M, Latinovic O, Sajadi MM, Redfield RR, Lafferty MK, Galli M, Garzino-Demo A, Gallo RC. 2012. Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of beta chemokines and RNases. Proc Natl Acad Sci U S A 109:5411-5416. http://dx.doi.org/10.1073/pnas.1202240109.
65. Bedoya VI, Boasso A, Hardy AW, Rybak S, Shearer GM, Rugeles MT. 2006. Ribonucleases in HIV type 1 inhibition: effect of recombinant RNases on infection of primary T cells and immune activation-induced RNase gene and protein expression. AIDS Res Hum Retroviruses 22:897-907. http://dx.doi.org/10.1089/aid.2006.22.897.
66. Stieh DJ, Matias E, Xu H, Fought AJ, Blanchard JL, Marx PA, Veazey RS, Hope TJ. 2016. Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques. Cell Host Microbe 19:529-540. http://dx.doi.org/10.1016/j.chom.2016.03.005.
67. Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, Banchereau J, Ueno H. 2014. The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of humanTFHcells. Nat Immunol 15:856-865. http://dx.doi.org/10.1038/ni.2947.
68. Xu H, Wang X, Malam N, Aye PP, Alvarez X, Lackner AA, Veazey RS. 2016. Persistent simian immunodeficiency virus infection drives differentiation, aberrant accumulation, and latent infection of germinal center follicular T helper cells. J Virol 90:1578-1587. http://dx.doi.org/10.1128/JVI.02471-15.
69. Allam A, Majji S, Peachman K, Jagodzinski L, Kim J, Ratto-Kim S, Wijayalath W, Merbah M, Kim JH, Michael NL, Alving CR, Casares S, Rao M. 2015. TFH cells accumulate in mucosal tissues of humanized-DRAG mice and are highly permissive to HIV-1. Sci Rep 5:10443. http://dx.doi.org/10.1038/srep10443.